Alps Group Inc ALPS
1.17 USD +0.02 (+1.74%)
Regular-session close
1.17 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
1.16 Day range 1.33
1.01 52-week range 8.60
- YTD
- -73.04%
- 1 year
- -73.83%
News
benzinga.com Alps Group Opens Pharmaco-interaction Laboratory Within Its MyGenome Unit PCI will start with cytochrome P450 (CYP450) inhibitory IC50 testing across seven major enzyme isoforms (CYP3A4, CYP2D6, CYP2C9, CYP1A2, CYP2C19, CYP2B6, and CYP2E1), collectively responsible for…
globenewswire.com Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing PCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety Science PCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety Sciencebenzinga.com Alps Group Shareholders Approve 1-For-5 Share Consolidation And Capital Increase Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that its shareholders approved, in accordance with Cayman…
